Chugai Pharmaceutical adopts observability platform “New Relic” for its own digital platform and generated AI apps
*New Relic Inc.*
Press release: September 3, 2024
**
Chugai Pharmaceutical adopts observability platform “New Relic” for its own digital platform and generated AI apps
*Improving the service quality of DX/AI apps that support the creation of innovative new drugs*
New Relic Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Konishi) provides an observability platform for digital businesses. Shinichiro (hereinafter referred to as “New Relic”) is a subsidiary of Chugai Pharmaceutical Co., Ltd. (Representative Director, President and CEO: Osamu Okuda, hereinafter referred to as “Chugai
Pharmaceutical”).
As part of the “strengthening of digital infrastructure” stated in “DIGITAL VISION 2030”, the observability platform “New
We are pleased to announce that we have introduced “Relic”.
* Background and history of introduction *
Chugai Pharmaceutical is an R&D-oriented pharmaceutical company with strengths in cancer fields and antibody drugs, and is accelerating its growth strategy through a strategic alliance with Roche. The driving force behind this is the continuous emergence of innovation symbolized by “AI drug discovery” and the use of digital technology to support this. Chugai Pharmaceutical Co., Ltd.
DIGITAL VISION
2030″ and is promoting “strengthening the digital infrastructure” that supports the entire value chain from drug discovery research to clinical development, manufacturing, and delivery.
Chugai Pharmaceutical is actively working to create an environment that will increase the productivity and speed of in-house development of DX/AI apps and quickly turn them into services. In July 2024, the multi-cloud company-wide infrastructure system “Chugai
Cloud
We have developed a platform called Acceleralyst that integrates a standardized technology stack on top of “Acceleralyst” (CCI). As one of its standard components, the observability platform New
Relic has been adopted.
*New Relic implementation and expected effects*
Chugai Pharmaceutical has launched “Chugai AI,” a generative AI app for business support for all of its approximately 7,600 employees. Assistant” was built on CCI and released in May 2024. Powered by Large-Scale Language Models (LLM), this Chat app uses AWS
Bedrock Claude3, Azure OpenAI GPT-4, GPT-4o, Google Gemini
You can freely use multiple LLMs such as Pro and MedLM specialized in the medical field. Chugai AI after release
Usage of Assistant has been steadily increasing, and now Monthly Active Approximately 3,500 users use the service, with peak usage reaching 1.8 million tokens per hour.
Chugai Pharmaceutical is using Chugai AI Assistant to monitor multi-cloud environments.
We use Relic to help us “quantitatively understand user experience” and “observe the usage status of LLM and cloud resources.”
In addition, New Relic AI allows you to apply application performance monitoring (APM) capabilities to your AI applications.
We aim to make full use of Chugai AI Assistant and create an environment where Chugai AI Assistant can be used more comfortably.
Chugai A.I.
Assistant has the feature that it can be used with confidence even for highly confidential tasks, and to achieve this, we are using AWS, Azure, Google
A closed network is used to connect to the cloud. In applying observability to application processes via closed networks, New The advanced technical support provided by Relic’s Japanese subsidiary also made a significant contribution, and we were able to implement the project in a short period of time.
* Ryosuke Kawabata, Group Manager, Agile Development Promotion Group, Digital Strategy Promotion Department, Digital Transformation Unit, Chugai Pharmaceutical Co., Ltd.
comment*
“It was a truly great achievement to be able to apply observability to a multi-cloud environment and AI applications in a short time.In the future, we will work on putting SRE activities into practice and establishing them.New
We hope that Relic will play a part in Chugai’s “strengthening of digital infrastructure” and that it will also help evolve the business observability field.”
*Comment from Shinichiro Konishi, President and CEO of New Relic* “New to Chugai Pharmaceutical’s “strengthening of digital
infrastructure” and challenge of DX/AI apps.
Relic is honored to be able to contribute. We will continue to provide technical support tailored to Chugai Pharmaceutical, so that they can make full use of observability and improve their business results.”
■Please see below for details on Chugai Pharmaceutical’s New Relic adoption case study.
https://newrelic.com/jp/customers/chugai-seiyaku
■Click here for the URL of this press release.
https://newrelic.com/jp/press-release/20240903
■You can see examples of New Relic adoption by other customers below. https://newrelic.com/jp/customers
■New Relic fact sheets and logos can be found below.
https://newrelic.com/jp/about/media-assets
* ■About New Relic*
New founded in 2008
As an industry leader, Relic provides an observability platform that enables observability of all important digital business metrics. By making it possible to monitor not only the applications and
infrastructure that make up a digital business, but also the customer experience on the user side, companies can detect failures in digital services, detect degradation of customer experience, and identify potential problems and bottlenecks. Create DevOps teams that identify and resolve early.
This enables companies to turn their digital transformation efforts into measurable strategies. New
Relic has over 16,000 customers worldwide, Fortune
It has been adopted by more than 100 companies, and supports the digital transformation of over 100 companies in Japan. New
To see why we support Relic, visit newrelic.com/jp.
* ■Features of observability platform “New Relic”*
New
Relic is a leader in observability, empowering engineers with a data-driven approach to planning, building, deploying, and running great software. New
Relic provides the only unified data platform for engineers to capture all their telemetry (metrics, events, logs, traces), combined with powerful full-stack analysis tools, so engineers can use data, not opinions, to create the best possible results. We will help you do your job. New
Relic has a simple and transparent pricing structure. It provides cost-effective results for engineers by helping them plan development cycle times, improve change failure rates, release frequency, and mean time to recovery (MTTR).
*New Relic is a registered trademark of New Relic, Inc.
*All product and company names in this document may be trademarks of their registered holders.
Forward-looking statements
This material has been prepared solely for the purpose of disclosing related information and does not constitute a solicitation or offer to purchase or sell securities. This document has been carefully prepared to ensure accuracy, but its completeness is not guaranteed.
Furthermore, in creating this material, we have relied on third-party information available to us, but we do not represent or warrant the actual accuracy or completeness of such third-party information. Our company assumes no responsibility for any damage caused by relying on the descriptions in this document.
The information in this document is subject to change without prior notice. This material contains forward-looking information regarding future expectations. These statements are based on current
expectations, projections and assumptions that involve risks, including, but not limited to, general economic and industry or market conditions that may differ materially from actual results. Possibly. The Company does not undertake any obligation to update or revise any forward-looking statements in this document, whether as a result of new information, the occurrence of future events, or for any other reason.